Myocarditis: imaging up to date

[1]  L. Cooper,et al.  Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management , 2020, Heart Rhythm.

[2]  Markus Velten,et al.  Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging. , 2020, Circulation. Cardiovascular imaging.

[3]  A. Amanullah,et al.  Myocardial injury and COVID-19: Possible mechanisms , 2020, Life Sciences.

[4]  C. Tondo,et al.  Cardiac and arrhythmic complications in patients with COVID‐19 , 2020, Journal of cardiovascular electrophysiology.

[5]  Roberto Maroldi,et al.  Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). , 2020, JAMA cardiology.

[6]  A. Faron,et al.  Comparison of Original and 2018 Lake Louise Criteria for Diagnosis of Acute Myocarditis: Results of a Validation Cohort. , 2019, Radiology. Cardiothoracic imaging.

[7]  S. Kligerman.  Imaging of Pericardial Disease. , 2019, Radiologic clinics of North America.

[8]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.

[9]  G. Veronese,et al.  Acute and Fulminant Myocarditis: a Pragmatic Clinical Approach to Diagnosis and Treatment , 2018, Current Cardiology Reports.

[10]  H. Lee,et al.  Utility of Dual-Energy CT-based Monochromatic Imaging in the Assessment of Myocardial Delayed Enhancement in Patients with Cardiomyopathy. , 2017, Radiology.

[11]  J. Leipsic,et al.  Update on Cardiovascular Applications of Multienergy CT. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[12]  Christopher A. Miller,et al.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases , 2017, The International Journal of Cardiovascular Imaging.

[13]  P. Steg,et al.  Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. , 2016, International journal of cardiology.

[14]  H. Lee,et al.  Myocardial Extracellular Volume Fraction with Dual-Energy Equilibrium Contrast-enhanced Cardiac CT in Nonischemic Cardiomyopathy: A Prospective Comparison with Cardiac MR Imaging. , 2016, Radiology.

[15]  S. Punwani,et al.  Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.

[16]  P. Croisille,et al.  Myocardial biomarkers and delayed enhanced cardiac magnetic resonance relationship in clinically suspected myocarditis and insight on clinical outcome , 2015, Journal of cardiovascular medicine.

[17]  M. Metra,et al.  Quantitative Analysis of Right Ventricular (RV) Function With Echocardiography in Chronic Heart Failure With No or Mild RV Dysfunction , 2015, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[18]  C. Catalano,et al.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.

[19]  Stuart A. Taylor,et al.  Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. , 2013, Radiology.

[20]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[21]  J. Bogaert,et al.  Pericardial disease: value of CT and MR imaging. , 2013, Radiology.

[22]  S. Iliceto,et al.  Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management , 2013, Heart Failure Reviews.

[23]  A. Angelini,et al.  2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. , 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[24]  J. Schwitter,et al.  [Cardiac magnetic resonance in acute myocarditis: a new non-invasive diagnostic gold standard?]. , 2012, Revue medicale suisse.

[25]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[26]  L. Cooper,et al.  Update on myocarditis. , 2012, Journal of the American College of Cardiology.

[27]  L. Cooper,et al.  The management of myocarditis. , 2011, European heart journal.

[28]  C. Catalano,et al.  Utility of T2-weighted short-tau inversion recovery (STIR) sequences in cardiac MRI: an overview of clinical applications in ischaemic and non-ischaemic heart disease , 2011, La radiologia medica.

[29]  K. Klingel,et al.  Human parvovirus B19-associated myocarditis. , 2010, The New England journal of medicine.

[30]  A. Hidrón,et al.  Cardiac Involvement with Parasitic Infections , 2010, Clinical Microbiology Reviews.

[31]  Albert C. Lardo,et al.  Applications of cardiac multidetector CT beyond coronary angiography , 2009, Nature Reviews Cardiology.

[32]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[33]  M. Budoff,et al.  Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Indi , 2008, Journal of the American College of Cardiology.

[34]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[35]  Barry J Maron,et al.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interd , 2006, Circulation.

[36]  W. Edwards,et al.  Eosinophilic-lymphocytic myocarditis after smallpox vaccination , 2003, The Lancet.

[37]  Wolfgang G Rehwald,et al.  Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury , 2002, Circulation.

[38]  J. Mason,et al.  Advances in the understanding of myocarditis. , 2001, Circulation.

[39]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.